Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of Tofacitinib in Rheumatoid Arthritis
NCT00413699Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2007
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 43
01
Overview
A Phase 3 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Feb 2007; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00413699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413699.